31 results
8-K
EX-99.4
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
concentrations of credit risk, such as foreign currency exchange contracts, option contracts, or other hedging arrangements. Financial instruments
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
. Dr. Morisset holds a degree, a masters and a Ph.D. from the University of Bordeaux.
Hedging Policy
Eliem’s Insider Trading Policy, adopted in 2021 … Eliem’s securities on margin or holding Eliem’s securities in margin accounts, hedging or monetization transactions, including through the use
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
. Dr. Morisset holds a degree, a masters and a Ph.D. from the University of Bordeaux.
Hedging Policy
Eliem’s Insider Trading Policy, adopted in 2021 … Eliem’s securities on margin or holding Eliem’s securities in margin accounts, hedging or monetization transactions, including through the use
DEFA14A
dl99j
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-10.5
xs16rod
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-2.1
wz11 5p0lkx8
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-10.1
bc2wmadq9ggp5kw1v
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-10.3
81zgyoubpy 95
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-10.2
9edahx0joomtz 2se
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
10-K
2mdq73tl 0k0dcpk6
7 Mar 22
Annual report
4:03pm